Prescription Drugs

(asked on 14th May 2021) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the Answer of 19 April 2021 to Question 179363, what steps his Department is taking to expedite guidance on medicines that have taken longer than the 90 days to receive final guidance from NICE; and whether his Department has plans to prioritise appraisals of medicines for clinically extremely vulnerable groups.


Answered by
Jo Churchill Portrait
Jo Churchill
Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
This question was answered on 21st May 2021

The 2019 Voluntary Scheme for Branded Medicines Pricing and Access commits the National Institute for Health and Care Excellence (NICE) to publishing recommendations on all newly licensed treatments within 90 days of marketing authorisation wherever possible.

NICE may not always be able to meet this timescale for individual topics for a range of reasons, including where companies request a longer appraisal timescale. In addition, during the COVID-19 pandemic, NICE adapted its priorities to support the health and care system at a time of unprecedented pressure. This involved pausing the publication of topics that were not COVID-19 related or regarded as therapeutically critical during the period of March to June 2020.

This content was generated for your convenience by Parallel Parliament and does not form part of the official record.
Recent Documents related to Prescription Drugs

1. Backbench business: Debate on a Motion relating to the NICE appraisals of rare diseases
12/03/2019 - Parliamentary Research

Found: PACK Number CDP-2019-0022, 12 March 2019 NICE appraisals of rare diseases By Tom Powell Michael O'Donnell

2. Report - Protecting and supporting the clinically extremely vulnerable during lockdown
10/02/2021 - National Audit Office

Found: National Audit Of˜ce logo SESSION 2019˜2021 10 FEBRUARY 2021 HC 1131 REPORT by the Comptroller and

3. Summary - Protecting and supporting the clinically extremely vulnerable during lockdown
10/02/2021 - National Audit Office

Found: National Audit Of˜ce logo SESSION 2019˜2021 10 FEBRUARY 2021 HC 1131 REPORT by the Comptroller and

4. COVID-19: letter to people identified as high risk – aged 70 and over
26/02/2021 - Public Health England (PHE)
- View source

Found: added to the list of people who are clinically extremely vulnerable (also known as the shielded patient

5. COVID-19: letter to people identified as high risk – aged 19 to 69
01/03/2021 - Public Health England (PHE)
- View source

Found: within the list of people who are clinically extremely vulnerable (also known as the shielded pa

Latest Documents
Recent Speeches related to Prescription Drugs

1. Oral Answers to Questions
13/07/2021 - Commons Chamber

1: the Exchequer on funding for a plan to reform social care for (a) older people and (b) people of working - Speech Link
2: without facing an astronomical care bill. We are committed to social care reform, and we will bring forward - Speech Link
3: Dilnot and almost 700 days since the Prime Minister promised“to fix social care, once and for all” - Speech Link

2. Oral Answers to Questions
23/02/2021 - Commons Chamber

1: billion package of additional welfare support in 2021. The Government keep all elements of their covid - Speech Link
2: support to those self-isolating has resulted in an extremely low adherence rate. Seventy per cent. of those - Speech Link
3: how keen the Health Secretary is to avoid scrutiny of the contracts that his Department have issued, - Speech Link

3. Oral Answers to Questions
17/11/2020 - Commons Chamber

1: constituency. The recent announcement regarding care homes is welcome. How quickly does he think the - Speech Link
2: terrible dilemma of wanting to keep people safe in care homes, yet also wanting to allow visiting. Testing - Speech Link
3: be able to support local authorities and public health teams with the logistics of mass testing, particularly - Speech Link

4. Covid-19 Vaccine Roll-out
08/12/2020 - Commons Chamber

1: Secretary of State for Health and Social Care, if he will make a statement on the covid-19 vaccine roll-out - Speech Link
2: first person in the world to receive a clinically authorised vaccine for covid-19. This marks the start of - Speech Link
3: hospital hub will get one? When will local primary care network hubs be announced, and when will the mass - Speech Link

5. Oral Answers to Questions
26/03/2019 - Commons Chamber

1: 1. What steps he is taking to help ensure better co-ordination with (a) the Department for Education - Speech Link
2: very honourable, and he has been an exceptional Health Minister.May I ask the Secretary of State - Speech Link
3: Winchester (Steve Brine) was an excellent public health Minister, who did exemplary work and drove the - Speech Link

Latest Speeches
Recent Questions related to Prescription Drugs
1. Department of Health and Social Care: Ethnic Groups
asked by: Ruth Jones
06/09/2021
... what recent estimate he has made of the number of Black and ethnic minority staff employed in his Department.

2. Department of Health and Social Care: Ethnic Groups
asked by: Seema Malhotra
25/07/2019
... (b) grade 5 and (c) grade 3 in his Department.

3. Department of Health and Social Care: Health
asked by: Chris Ruane
25/10/2019
... whether his Department uses Office for National Statistics estimates of personal well-being in formulating policy; and what policies his Department has introduced to improve personal well-being in the last 12 months.

4. Department of Health and Social Care
asked by: Ed Davey
25/06/2020
... Chief Executive of NHS Providers since February 2020.

5. Department of Health and Social Care
asked by: Ed Davey
25/06/2020
... how many meetings (a) he and (b) his Ministers have had with (a) Professor Kevin Fenton and (b) Professor John Newton.

Latest Questions